Type at least 2 characters to search.
View all results →
PCYC (Pacific CRO)
Taipei, Taiwan
About CRO
Taiwanese CRO providing clinical trial management, regulatory consulting, and bioequivalence studies for the Asia-Pacific pharmaceutical market.
Technology & Expertise
PCYC is presented on CROaccess as a Taiwan-based clinical research provider supporting clinical-trial operations, regulatory consulting, bioequivalence work, and bioanalytical services. Relevant capabilities may include local site and investigator coordination, study start-up, clinical monitoring, electronic data collection, statistical analysis, and preparation of documents for Taiwan and Asia-Pacific development programs. A current official corporate website and detailed technology inventory could not be independently verified, so sponsors should request a current capability statement before qualification.
Core Services
The listed service scope includes clinical project management, feasibility and site selection, regulatory and ethics submissions, site activation, clinical monitoring, data management and biostatistics, bioavailability and bioequivalence study support, bioanalytical coordination, safety reporting, and clinical-study documentation. The provider may be best suited to sponsors seeking local execution and regulatory support in Taiwan or the wider Asia-Pacific region. Exact therapeutic experience, staffing, facilities, and geographic coverage should be confirmed directly.
Accreditations & Compliance
Clinical work in Taiwan should follow the applicable Taiwan Food and Drug Administration and ethics-review requirements together with ICH Good Clinical Practice, participant-protection, safety-reporting, data-integrity, and privacy obligations. Bioequivalence or bioanalytical work may also require facility-specific GCP, GLP, GCLP, method-validation, and sample-chain-of-custody controls. CROaccess could not independently verify current PCYC accreditations, licenses, or inspection history; these documents should be obtained and reviewed during sponsor due diligence before awarding work.